CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

MHRA (UK)
Original article

Vimseltinib (romvimza) approved for use in adults to treat tenosynovial giant cell tumours

Vimseltinibvimseltinib
Related Companies

Read the original article

Published by MHRA (UK) on August 14, 2026 11:34 AM

Read Original